InvestorsHub Logo
Followers 18
Posts 632
Boards Moderated 1
Alias Born 02/07/2012

Re: None

Thursday, 04/18/2013 8:36:44 PM

Thursday, April 18, 2013 8:36:44 PM

Post# of 50129
FRTD - have been adding, like the upside. I have full faith in management and the FDA approved product.

Go FRTD !!!. We can thank Birmingham and his buddies , you know guys like Jim Kelly etc.. for killing this stock. Not current management. Time will tell who is right and who is wrong. I have a feeling I will be on the side that is right. How anyone can praise John Stanton and his band of thieves is beyond me, unless maybe you were one of them.

On January 29, 2013 - Fortitude Group Inc., announced the acquisition of Legacy Life Science (L2S)

The L2S premium product portfolio contains the Comprehensive Airway Management System consisting of five, patented FDA approved products ready for worldwide distribution and sales. The Comprehensive Airway Management System is engineered to significantly reduce and prevent respiratory distress in the perioperative procedural sedation environment (anesthesia). A common scenario in peri-operative procedural sedation involves degradation of patient airway monitoring and management; and therefore, constitutes the designation as a Hospital Acquired Condition or (HAC) for respiratory related distress.

The L2S Comprehensive Airway Management System meets the new ASA Standards.